PET and SPECT tracers for glutamate receptors

Drug Discovery Today

Volumn 18, Issue 3-4, 2013, Pages 173-184

  Majo, Vattoly J ^a   Prabhakaran, Jaya ^a   Mann, J John ^a,b   Kumar, J S Dileep ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 METHYL PYRIDIN 2 YLETHYNYL)CYCLOHEX 2 ENONE O C 11; 6,7 DICHLORO 5 NITRO 2,3 QUINOXALINEDIONE; [1 (3 IODOPHENYL) 1 METHYL 3 (NAPHTHALEN 1 YL)GUANIDINE]; [2 (2 CARBOXYCYCLOPROPYL) 2 (4 [11C]METHOXY PHENETHYL)GLYCINE DIMETHYL ESTER] C 11; ABP 688; ABP 688 C 11; ACEA 1021 C 11; CMG C 11; CNS 1261; CNS 5161; CNS 5161 C 11; DELUCEMINE; FDEGPECO F 18; FE DABP 688; FE DABP 688 F 18; FITM F 18; FLUOROMEMANTINE F 18; FPECMO F 18; FPIT F 18; FPTQ F 18; FTIDC F 18; GMOM C 11; I PAMQX I 131; JNJ 16567083; JNJ 16567083 C 11; JNJ 42491293; JNJ 42491293 C 11; KETAMINE C 11; METABOTROPIC RECEPTOR 1; MK 1312; MMTP C 11; NPS 1506 C 11; PSS 223; PSS 223 F 18; RADIOLIGAND; RADIOPHARMACEUTICAL AGENT; RO 647312; RO 647312 C 11; RPR 104632; RPR 104632 BR 76; SP 203; UNCLASSIFIED DRUG; UNINDEXED DRUG; YM 202074; YM 202074 C 11;

HUMAN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ANIMALS; BRAIN; HUMANS; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; RECEPTORS, GLUTAMATE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84873099162     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2012.10.004     Document Type: Review

References (121)

1. D.R. Madden The structure and function of glutamate receptor ion channels Nat. Rev. Neurosci. 3 2002 91 101
2. F. Nicoletti Metabotropic glutamate receptors: from the workbench to the bedside Neuropharmacology 60 2011 1017 1041
3. P. Stawski Pharmacology of ionotropic glutamate receptors: a structural perspective Bioorg. Med. Chem. 18 2010 7759 7772
4. A. Lau, and M. Tymianski Glutamate receptors, neurotoxicity and neurodegeneration Pflugers Arch. Eur. J. Phys. 460 2010 525 542
5. S.L. Pimlott, and A. Sutherland Molecular tracers for the PET and SPECT imaging of disease Chem. Soc. Rev. 40 2011 149 162
6. S.M. Ametamey Molecular imaging with PET Chem. Rev. 108 2008 1501 1516
7. W.C. Eckelman Discussion of targeting proteins in vivo: in vitro guidelines Nucl. Med. Biol. 33 2006 449 451
8. S. Bleich Glutamate and the glutamate receptor system: a target for drug action Int. J. Geriatr. Psychiatry 18 2003 S33 S40
9. J. Bockaert Metabotropic glutamate receptors: an original family of G protein-coupled receptors Fundam. Clin. Pharmacol. 7 1993 473 485
10. D.D. Schoepp Novel functions for subtypes of metabotropic glutamate receptors Neurochem. Int. 24 1994 439 449
11. J.H. Krystal Potential psychiatric applications of metabotropic glutamate receptor agonists and antagonists CNS Drugs 24 2010 669 693
12. S. Nakanishi Glutamate receptors: brain function and signal transduction Brain Res. Brain Res. Rev. 26 1998 230 235
13. F.M. Ribeiro Group I metabotropic glutamate receptor signalling and its implication in neurological disease CNS Neurol. Disord. Drug Targets 9 2010 574 595
14. 18F]F-PEB Nucl. Med. Biol. 34 2007 1009 1017
15. L. Mu Radioligands for the PET imaging of metabotropic glutamate receptor subtype 5 (mGluR5) Curr. Top. Med. Chem. 10 2010 1558 1568
16. M. Yu Methoxyphenylethynyl, methoxypyridylethynyl and phenylethynyl derivatives of pyridine: synthesis, radiolabeling and evaluation of new PET ligands for metabotropic glutamate subtype 5 receptors Nucl. Med. Biol. 32 2005 631 640
17. M. Kokic Radiolabeling and in vivo evaluation of [C] M-MPEP as a PET radioligand for the imaging of the metabotropic glutamate receptor 5 (mGluR5)11 J. Label. Compd. Radiopharm. 44 2001 S231 S232
18. 11C]MPEPy as a potential PET ligand for mGlu5 receptors Nucl. Med. Biol. 33 2006 1021 1027
19. Kessler, L.J. (2004) Development of novel ligands for PET imaging of metabotropic glutamate receptor subtype 5 (mGLuR5). Dissertation No. 15633 ETH-Zürich.
20. 11C] copper(I) cyanide J. Label. Compd. Radiopharm. 49 2006 829 834
21. J.Q. Wang Synthesis and preliminary biological evaluation of 3-[(18)F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5 Synapse 61 2007 951 961
22. O. Barret Quantitation of glutamate mGluR5 receptor with 18F-FPEB PET in humans J. Nucl. Med. Meeting Abstr. 51 2010 215
23. S.M. Krause In vivo characterizations of PET ligands for the mGluR5 receptor in rhesus monkey Mol. Imaging Biol. 5 2003 166
24. T.G. Hamill Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers Synapse 56 2005 205 216
25. A.K. Brown Metabotropic glutamate subtype 5 receptors are quantified in the human brain with a novel radioligand for PET J. Nucl. Med. 49 2008 2042 2048
26. 18F-labeling of 3-fluoro-5-(2-(2-(fluoromethyl)thiazol-4-yl)ethynyl)benzonitrile as a high affinity radioligand for imaging monkey brain metabotropic glutamate subtype-5 receptors with positron emission tomography J. Med. Chem. 50 2007 3256 3266
27. 18F-SP203, to image metabotropic glutamate subtype 5 receptors in humans Eur. J. Nucl. Med. Mol. Imaging 37 2010 1943 1949
28. S. Telu Syntheses of mGluR5 PET radioligands through the radiofluorination of diaryliodonium tosylates Org. Biomol. Chem. 9 2011 6629 6638
29. 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5 J. Nucl. Med. 47 2006 698 705
30. D. Elmenhorst Test-retest stability of cerebral mGluR(5) quantification using [(11)C]ABP688 and PET in rats Synapse 66 2012 552 560
31. C. DeLorenzo In vivo positron emission tomography imaging with [(11)C]ABP688: binding variability and specificity for the metabotropic glutamate receptor subtype 5 in baboons Eur. J. Nucl. Med. Mol. Imaging 38 2011 1083 1094
32. 11C-ABP688 J. Nucl. Med. 48 2007 247 252
33. N. Miyake Imaging changes in glutamate transmission in vivo with the metabotropic glutamate receptor 5 tracer [(11)C] ABP688 and N-acetylcysteine challenge Biol. Psychiatry 69 2011 822 824
34. 11C]ABP688 PET and postmortem study Am. J. Psychiatry 168 2011 727 734
35. 18F]-FE-DABP688 as a PET radioligand for the metabotropic glutamate receptor subtype 5 Nucl. Med. Biol. 34 2007 973 980
36. 18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5 Nucl. Med. Biol. 36 2009 613 622
37. C.A. Baumann Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET) J. Med. Chem. 53 2010 4009 4017
38. 18F]-FDEGPECO as a PET tracer for imaging the metabotropic glutamate receptor subtype 5 (mGluR5) Neuroimage 56 2011 984 991
39. S.M. Sephton Development of [(18)F]-PSS223 as a PET tracer for imaging of metabotropic glutamate receptor subtype 5 (mGluR5) Chimia 66 2012 201 204
40. F. Ferraguti Metabotropic glutamate 1 receptor: current concepts and perspectives Pharmacol. Rev. 60 2008 536 581
41. A. Gravius Metabotropic glutamate receptors as therapeutic targets for cognitive disorders Curr. Top. Med. Chem. 10 2010 187 206
42. E.D. Hostetler Synthesis, characterization, and monkey PET studies of [(18)F]MK-1312, a PET tracer for quantification of mGluR1 receptor occupancy by MK-5435 Synapse 65 2011 125 135
43. 11C] methyl-6-quinolinyl)(cis-4-methoxycyclohexyl)methanone J. Med. Chem. 48 2005 5096 5099
44. 11C]YM-202074 as a PET ligand for imaging the metabotropic glutamate receptor type 1 Nucl. Med. Biol. 37 2010 615 624
45. 11C]MMTP: a potential PET ligand for mGluR1 receptors Bioorg. Med. Chem. Lett. 20 2010 3499 3501
46. A. Satoh Discovery and in vitro and in vivo profiles of 4-fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-N-methy lbenzamide as novel class of an orally active metabotropic glutamate receptor 1 (mGluR1) antagonist Bioorg. Med. Chem. Lett. 19 2009 5464 5468
47. 18F]fluoro-N-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl] -N-methylbenzamide as a new positron emission tomography ligand for metabotropic glutamate receptor subtype 1 Bioorg. Med. Chem. Lett. 21 2011 2998 3001
48. 18F]FITM Eur. J. Nucl. Med. Mol. Imaging 39 2012 632 641
49. 18F]FTIDC: a new PET radioligand for metabotropic glutamate receptor 1 Eur. J. Nucl. Med. Mol. Imaging 36 2009 S310
50. M. Fujinaga Characterization of 1-(2-[(18)F]fluoro-3-pyridyl)-4-(2- isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole, a PET ligand for imaging the metabotropic glutamate receptor type 1 in rat and monkey brains J. Neurochem. 121 2012 115 124
51. M. Fujinaga Synthesis and evaluation of 6-[1-(2-[(18)F]fluoro-3-pyridyl)- 5-methyl-1H-1,2,3-triazol-4-yl]quinoline for positron emission tomography imaging of the metabotropic glutamate receptor type 1 in brain Bioorg. Med. Chem. 19 2011 102 110
52. D.D. Schoepp Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20
53. Y. Tamaru Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location relative to pre- and postsynaptic sites Neuroscience 106 2001 481 503
54. R.S. Petralia The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976
55. T. Phillips Localization of metabotropic glutamate receptor type 2 in the human brain Neuroscience 95 2000 1139 1156
56. A. Makoff Molecular characterization and localization of human metabotropic glutamate receptor type 3 Brain Res. Mol. Brain Res. 40 1996 55 63
57. G.J. Marek Metabotropic glutamate2/3 (mGlu2/3) receptors, schizophrenia and cognition Eur. J. Pharmacol. 639 2010 81 90
58. 11C]CMG) J. Nucl. Med. Meeting Abstr. 49 2008 286P-b
59. 11C]JNJ42491293 as a radioligand for PET imaging of mGluR2 in brain J. Nucl. Med. Meeting Abstr. 53 2012 286
60. 11C]JNJ-42491293, a PET tracer for the mGluR2 receptor in the human brain J. Nucl. Med. Meeting Abstr. 53 2012 355
61. H. Lavreysen, and F.M. Dautzenberg Therapeutic potential of group III metabotropic glutamate receptors Curr. Med. Chem. 15 2008 671 684
62. R.M. Duvoisin Acute pharmacological modulation of mGluR8 reduces measures of anxiety Behav. Brain Res. 212 2010 168 173
63. C. Corti Distribution and synaptic localisation of the metabotropic glutamate receptor 4 (mGluR4) in the rodent CNS Neuroscience 110 2002 403 420
64. C.W. Lindsley Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's disease Curr. Top. Med. Chem. 9 2009 949 963
65. S. Celanire, and B. Campo Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders Expert Opin. Drug Discov. 7 2012 261 280
66. 11C]methyl- PHCCC) as a specific mGluR4 PET ligand J. Nucl. Med. Meeting Abstr. 49 2008 288P-c
67. D.W. Engers Discovery, synthesis, and structure-activity relationship development of a series of N-(4-acetamido)phenylpicolinamides as positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu(4)) with CNS exposure in rats J. Med. Chem. 54 2011 1106 1110
68. D.B. Tikhonov, and L.G. Magazanik Origin and molecular evolution of ionotropic glutamate receptors Neurosci. Behav. Physiol. 39 2009 763 773
69. M. Larsson, and J. Broman Synaptic plasticity and pain: role of ionotropic glutamate receptors Neuroscientist 17 2011 256 273
70. G.N. Barnes, and J.T. Slevin Ionotropic glutamate receptor biology: effect on synaptic connectivity and function in neurological disease Curr. Med. Chem. 10 2003 2059 2072
71. A. Schurr Neuroprotection against ischemic/hypoxic brain damage: blockers of ionotropic glutamate receptor and voltage sensitive calcium channels Curr. Drug Targets 5 2004 603 618
72. D. Bowie Ionotropic glutamate receptors & CNS disorders CNS Neurol. Disord. Drug Targets 7 2008 129 143
73. M.E. Flores-Soto Structure and function of NMDA-type glutamate receptor subunits Neurologia 27 2012 301 310
74. M.H. Ulbrich, and E.Y. Isacoff Rules of engagement for NMDA receptor subunits Proc. Natl. Acad. Sci. U. S. A. 105 2008 14163 14168
75. A.W. Dunah Biochemical studies of the structure and function of the N-methyl-d-aspartate subtype of glutamate receptors Mol. Neurobiol. 19 1999 151 179
76. P.E. Chen, and D.J. Wyllie Pharmacological insights obtained from structure-function studies of ionotropic glutamate receptors Br. J. Pharmacol. 147 2006 839 853
77. M. Gielen Mechanism of differential control of NMDA receptor activity by NR2 subunits Nature 459 2009 703 707
78. M. Eriksson On the role of NR3A in human NMDA receptors Physiol. Behav. 92 2007 54 59
79. K.S.L. Wee Immunolocalization of NMDA receptor subunit NR3B in selected structures in the rat forebrain, cerebellum, and lumbar spinal cord J. Comp. Neurol. 509 2008 118 135
80. L. Dobrek, and P. Thor Glutamate NMDA receptors in pathophysiology and pharmacotherapy of selected nervous system diseases Postepy Hig. Med. Dosw. 65 2011 338 346
81. F. Sobrio PET and SPECT imaging of the NMDA receptor system: an overview of radiotracer development Mini Rev. Med. Chem. 10 2010 870 886
82. T. Haradahira Synthesis and brain distribution of carbon-11 labeled analogs of antagonists for the NMDA receptor coupled PCP-binding site J. Label. Compd. Radiopharm. 41 1998 843 858
83. 18F]3- fluoromethyl-TCP: a potent ligand for the NMDA glutamatergic receptor J. Label. Compd. Radiopharm. 22 1993 255 256
84. 18F]-fluoromethyl-TCP1, a potential tool for pet study of the NMDA receptor channel complex J. Label. Compd. Radiopharm. 31 1992 955 960
85. 11C]MK801] Appl. Radiat. Isotopes 41 1990 139 142
86. 123I]Iodo-MK-801: synthesis and characterization of binding to the N-methyl-d-aspartate receptor complex Life Sci. 46 1990 1103 1110
87. 123Iodo-MK-801: a spect agent for imaging the pattern and extent of glutamate (NMDA) receptor activiation in Alzheimer's disease J. Psychiatr. Res. 31 1997 605 619
88. 11C-labelled 9,10-ethanobenzo [b]quinolizinium derivatives for imaging of the NMDA receptor at the TCP-binding site J. Label. Compd. Radiopharm. 43 2000 375 383
89. 11C]3MPICA) as a PET radiotracer for the glycine site of the NMDA ion channel Nucl. Med. Biol. 29 2002 791 794
90. 11C]GMOM) as a potential PET radiotracer for the PCP/NMDA receptor Nucl. Med. Biol. 31 2004 939 948
91. 11C]CNS 5161, a candidate PET tracer for functional imaging of NMDA receptors J. Label. Compd. Radiopharm. 49 2006 163 170
92. 11C]CNS 5161, a novelputative NMDA ion channel PET ligand Neuroimage 22 Suppl. 2 2004 T54 T55
93. 125I]-CNS 1261): a potential SPECT agent for imaging NMDA receptor activation Nucl. Med. Biol. 27 2000 557 564
94. R.J. Knol In vivo [(123)I]CNS-1261 binding to D-serine-activated and MK801-blocked NMDA receptors: a storage phosphor imaging study in rats Synapse 63 2009 557 564
95. 123I]CNS-1261 SPET study Psychopharmacology (Berl) 197 2008 401 408
96. 11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy Epilepsia 40 1999 30 37
97. S.M. Ametamey Fluorine-18 radiolabelling, biodistribution studies and preliminary PET evaluation of a new memantine derivative for imaging the NMDA receptor J. Recept. Signal Transduct. 19 1999 129 141
98. 18F-MEM): a potential radioligand for mapping the NMDA-receptor complex Nucl. Med. Biol. 25 1998 323 330
99. 18F-memantine in healthy volunteers Nucl. Med. Biol. 29 2002 227 231
100. 11C]methyl-BIII277CL for imaging the PCP-binding site of the nmda receptor by PET J. Recept. Signal Transduct. 22 2002 123 139
101. 11C]NPS 1506 in mice and rat: an N-methyl-d-aspartate (NMDA) receptor antagonist Biol. Pharm. Bull. 26 2003 1570 1573
102. 11C]L-703,717, a PET radioligand for the glycine-binding site of NMDA receptors Synapse 50 2003 130 136
103. 11C]methoxybenzyl) phenyl]-2(1H)- quinolone (AcL703) with positron emission tomography Synapse 61 2007 795 800
104. 11C]methylamino 4-hydroxy-2(1H)-quinolone derivatives as PET radioligands for the glycine-binding site of NMDA receptors Bioorg. Med. Chem. 17 2009 5665 5675
105. 11C-labelled nitrated 1,4-dihydroquinoxaline-2,3-dione, the NMDA glycine receptor antagonist ACEA 1021 (Licostinel) J. Label. Compd. Radiopharm. 41 1998 345 353
106. 76Br]RPR 104632 for in vivo studies of the NMDA receptor channel complex J. Label. Compd. Radiopharm. 40 1997 608 610
107. 11C]EMD-95885: a high affinity ligand for NR2B-containing NMDA receptors Bioorg. Med. Chem. 12 2004 3229 3237
108. 11C]oxo-1,3-dihydrobenzimidazol-5-yl)oxamide, a NR2B-selective NMDA receptor antagonist J. Label. Compd. Radiopharm. 53 2010 63 67
109. 11C]methoxyphenyl)piperidino]-1-propanol, as a PET tracer for NR2B subunit-containing NMDA receptors Nucl. Med. Biol. 29 2002 517 525
110. 11C]Ro-647312: a novel NR1/2B subtype selective NMDA receptor radioligand J. Label. Compd. Radiopharm. 47 2004 911 920
111. T.G. Hamill The synthesis of a benzamidine-containing NR2B-selective NMDA receptor ligand labelled with tritium or fluorine-18 J. Label. Compd. Radiopharm. 48 2005 1 10
112. 11C-labelled bis(phenylalkyl)amines and their in vitro and in vivo binding properties in rodent and monkey brains Biol. Pharm. Bull. 27 2004 531 537
113. D. Bowie Redefining the classification of AMPA-selective ionotropic glutamate receptors J. Physiol. 590 2012 49 61
114. H.W. Kessels, and R. Malinow Synaptic AMPA receptor plasticity and behavior Neuron 61 2009 340 350
115. I.R. Mellor The AMPA receptor as a therapeutic target: current perspectives and emerging possibilities Future Med. Chem. 2 2010 877 891
116. M. Gao Synthesis of carbon-11 and fluorine-18 labeled N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as new potential PET AMPA receptor ligands Bioorg. Med. Chem. Lett. 16 2006 2229 2233
117. 11C]methoxy-1,2,3,4- tetrahydrois oquinoline as a potential PET tracer Bioorg. Med. Chem. 14 2006 4712 4717
118. 18F]Fluorobenzamido)phenyl)- propyl-2-propanesulphonamide: synthesis and radiofluorination of a putative AMPA receptor ligand J. Label. Compd. Radiopharm. 50 2007 1169 1175
119. A. Contractor Kainate receptors coming of age: milestones of two decades of research Trends Neurosci. 34 2011 154 163
120. C. Matute Therapeutic potential of kainate receptors CNS Neurosci. Ther. 17 2011 661 669
121. 11C-labeled PET tracer for exploration of the site of action of acromelic acid a in allodynia induction Bioorg. Med. Chem. Lett. 21 2011 2017 2020